Differences between CTAB and chitosan in modifying PLGA nanoparticles for gene therapy
Poly (D, L-Lactic-co-Glycolic Acid) (PLGA) nanoparticles were modified by adding cetyltrimethylammonium bromide (CTAB) to the aqueous phase (F1) or oil phase (F2), or by low (F3) or medium (F4) molecular weight chitosan. Nanoparticles were characterised for their physicochemical and biological prope...
Main Authors: | Doolaanea, Abd Almonem, Mansor, Nur 'Izzati, Mohd Nor, Nurul Hafizah, Mohamed, Farahidah |
---|---|
Format: | Conference or Workshop Item |
Language: | English English |
Published: |
UKM Kuala Lumpur Campus
2015
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/46387/ http://irep.iium.edu.my/46387/4/Monem_CRDDS2015.pdf http://irep.iium.edu.my/46387/7/46387_Differences_Between_CTAB_Abstract.pdf |
Similar Items
-
Fabrication of non-viral gene delivery system of N.sativa/chitosan/PLGA nanoparticles
by: Mansor, Nur 'Izzati, et al.
Published: (2013) -
Alzheimer disease: gene therapy and natural product research
by: Doolaanea, Abd Almonem, et al.
Published: (2018) -
Co-encapsulation of Nigella sativa oil and plasmid DNA for enhanced gene therapy of Alzheimer’s disease
by: Doolaanea, Abd Almonem, et al.
Published: (2016) -
Quantification of Nigella sativa oil (NSO) from biodegradable PLGA nanoparticles using FTIR spectroscopy
by: Doolaanea, Abd Almonem, et al.
Published: (2014) -
Co-encapsulation of NIgella sativa oil with plasmid DNA into biodegradable PLGA nanoparticle
by: Doolaane, Abd Monem, et al.
Published: (2013)